I am a vaccine safety scientist at the Vaccine Evaluation Center, a leading center for applied vaccine research in Canada. My research interests include vaccine safety and vaccine preventable diseases, as well as attitudes and beliefs around immunization uptake and use. I am also the epidemiologist for the Immunization Monitoring Program, Active, a national surveillance system for vaccine preventable diseases and vaccine adverse events in 12 pediatric tertiary care centers across Canada. I lead PCIRN’s National Ambulatory Network, a national surveillance system monitoring the safety of influenza vaccines in Canada.
Michael Smith Foundation for Health Research Career Award
Gareth Mercer, MD/PhD student
Amy Slogrove, PhD student
Amy Schneeberg, PhD student
MPH practicum students: Emily LaFlamme, Laura Ball, Michelle Chang
Bettinger JA, Deeks SL, Halperin SA, Tsang R and Scheifele DW. Controlling serogroup B invasive meningococcal disease: the Canadian perspective. Expert Rev Vaccines 2013; 12(5):505-517.
Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R. The disease burden of invasive meningococcal serogroup B disease in Canada. PIDJ 2013; 32(1) e20-e25.
Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Vanderkooi OG, Schryvers A, De Serres G, Alcantara J. Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis. Vaccine 2012; 30:4023-27.
De Serres G, Gariépy M-C, Coleman B, Rouleau I, McNeil S, Benoît M, McGeer A, Ambrose A, Needham J, Bergeron C, Grenier C, Sleigh K, Kallos A, Ouakki M, Ouhoummane N, Stiver G, Valiquette L, McCarthy A, Bettinger J on behalf of the PHAC-CIHR Influenza Research Network (PCIRN). Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine. PLoS ONE; 7(7):e38563 (p1-7).
Dubé E, Laberge C, Guay M, Bramadat P, Roy R and Bettinger J. Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics 2013; 9(8):1-11.
Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, and Law B, for Members of the Canadian Immunization Monitoring Program, Active (IMPACT). The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT Centers, Canada, 2000-2008. PIDJ 2012; 31(9):956-63.
Vaccine preventable diseases: meningococcal, pneumococcal, influenza, rotavirus
Immunization knowledge, attitudes and beliefs
Infectious disease epidemiology
Population based active surveillance for meningococcal infections in adults and children across Canada
Evaluation of meningococcal immunization programs across Canada
Immunization Monitoring Program, Active (IMPACT): hospital-based active surveillance for vaccine preventable diseases and adverse events following immunization
Parental attitudes about rotavirus vaccination
Parental attitudes about immunization after an adverse event following immunization